Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Brain Lang. 2012 Aug 19;127(1):65–74. doi: 10.1016/j.bandl.2012.07.008

Table 1.

Individual patient information and group means (standard deviations) for age (years), education (years), WTAR standard score (max = 34), MMSE2 (max = 30), UPDRS (max = 108), time since diagnosis (years), Hoehn-Yahr stage (max = 4), medication status at time of testing, and daily medication DOPA-equivalent dose (mg).

Patients Gender Age Education WTAR-Std MMSE2 UPDRS Years since diagnosis Hoehn-Yahr Status at testing DOPA equivalence
P1 M 75 21 107 27 17 3.5 2 ON 750
P2 F 77 12 108 30 24 4.5 3 ON 350
P3 M 60 15 123 30 12 2 1 OFF 0
P4 F 59 16 110 26 21 4 2 ON up to 600
P5 F 52 16 104 30 25 9 2 ON 700–1000
P6 F 63 13 102 29 21 2 2 ON 800
P7 M 65 19 104 26 47 14 4 ON 750
P8 F 72 14 104 27 22 10 2 ON 600
P9 F 68 16 113 30 29 10 2 ON 800
P10 M 60 14 107 27 57 2.5 3 OFF 600
P11 M 64 12 96 27 45 6 3 ON 150
P12 M 67 19 93 28 68 5 4 OFF 1550
P13 M 74 14 99 28 43 6 2 ON 200
P14 F 60 18 102 28 24 7 2 ON variable
P15 M 37 17 113 30 10 5 2 ON 750
P16 M 65 18 123 30 26 2 2 ON 200
P17 F 62 28 125 30 10 8 1 ON 200–500
P18 M 80 13 121 28 25 9 2 ON 850
P19 M 61 19 123 29 10 1.5 1.5 ON 100
P20 F 69 18 122 26 18 2.5 2 ON 200
Patient 9/20 F 64.5 (9.5) 16.6 (3.7) 110 (9.9) 28.3 (1.5) 27.7 (16.1) 5.7 (3.4) 2.3 (0.8)
Control 12/22 F 65.4 (6.1) 16.2 (1.9) 115.9 (6.6) 28.9 (0.9)